Chemical Name: Zaleplon
Trade Name: Sonata
Description: Hypnotic agent with a chemical structure unrelated to benzodiazepines, barbituates, or other drugs with known hypnotic properties. It interacts with the GABA-Benzodiazepine receptor complex.
Indication: Indicated for the short term treatment of insomnia.
Contraindications, Warnings, and Precautions: Hypnotics should generally be limited to 7 - 10 days of use. A variety of abnormal thinking and behavior changes have been reported to occur in association with the use of sedative/hypnotics such as bizarre behavior, agitation, hallucinations, and depersonalization. In primarily depressed patients, sedatives and hypnotics may cause a worsening of depression. Because of the rapid onset of action, do not ingest Sonata until immediately prior to going to bed. Do not use with alcohol. Sonata does have a potential for abuse.
Adverse Reactions: Possible common side effects may include constipation, dry mouth, migraine, depression, hypertonia, nervousness, and difficulty concentrating.
Dosing: Typically 10 mg at night. Doses should not exceed 20 mg.
These pages are solely for public informational purposes. The information cannot be relied on to make diagnoses or prescribe treatment in any individual. Persons who require such services should consult with a licensed professional.
Send mail to firstname.lastname@example.org with questions or comments about this web site.
© 2000 Red Oak Psychiatry Associates, P.A. Updated